| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
46,500,000 |
| Market
Cap: |
12.56(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.272 - $1.905 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Enochian BioSciences is a pre-clinical stage biotechnology company. Co.'s product candidates include: ENOB-HV-01 for autologous Human Immunodeficiency Virus (HIV) curative treatment; ENOB-HV-11 for preventive HIV vaccine; ENOB-HV-12 for therapeutic HIV vaccine; ENOB-HV-21 for HIV natural killer and gamma delta T-cell treatment or cure; ENOB-HV-31 for in vivo gene therapy; ENOB-HB-01 for hijacking Hepatitis B Virus polymerase; ENOB-CV-01 for coronavirus treatment; ENOB-CV-11 for coronavirus prophylaxis; ENOB-FL-01 for influenza treatment; ENOB-FL-11 for influenza prophylaxis; and ENOB-DC-11 for off the shelf dendritic cell vaccine for multiple solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,430 |
473,180 |
| Total Sell Value |
$0 |
$0 |
$56,292 |
$725,538 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
3 |
14 |
| End Date |
2025-04-13 |
2025-01-10 |
2024-07-12 |
2023-07-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  William Anderson Wittekind |
|
– – • |
2025-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(350,000) |
3,353,878 |
|
- |
|
| Van Tilburg Maurice |
Director |
– • – |
2025-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
|
- |
|
| Weinstein David Hershel |
Chief Executive Officer |
• • – |
2024-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
|
- |
|
| Miller Avram |
Director |
– • – |
2024-08-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(833,333) |
166,667 |
|
- |
|
| Brink Karen |
Director |
– • • |
2024-08-12 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,000,000 |
25,372,969 |
|
- |
|
| Brink Karen |
Director |
– • • |
2024-08-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,000,000) |
23,372,969 |
|
- |
|
| William Anderson Wittekind |
|
– – • |
2024-07-29 |
4 |
S |
$1.30 |
$1,448 |
I/I |
(1,114) |
840,319 |
|
-23% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-17 |
4 |
S |
$1.46 |
$23,889 |
I/I |
(16,362) |
841,433 |
|
64% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-15 |
4 |
S |
$1.41 |
$30,955 |
I/I |
(21,954) |
875,795 |
|
64% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-11 |
4 |
S |
$1.51 |
$22,493 |
I/I |
(14,896) |
897,749 |
|
66% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-10 |
4 |
S |
$1.51 |
$113,250 |
I/I |
(75,000) |
894,645 |
|
67% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-09 |
4 |
S |
$1.53 |
$7,084 |
I/I |
(4,630) |
969,645 |
|
61% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-05 |
4 |
S |
$1.55 |
$93,000 |
I/I |
(60,000) |
974,275 |
|
61% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-03 |
4 |
S |
$1.51 |
$75,500 |
I/I |
(50,000) |
1,034,275 |
|
61% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-02 |
4 |
S |
$1.54 |
$53,212 |
I/I |
(34,553) |
1,084,275 |
|
59% |
|
| William Anderson Wittekind |
|
– – • |
2024-07-01 |
4 |
S |
$1.56 |
$93,600 |
I/I |
(60,000) |
1,118,828 |
|
64% |
|
| William Anderson Wittekind |
|
– – • |
2024-06-27 |
4 |
S |
$1.50 |
$22,007 |
I/I |
(14,671) |
1,178,828 |
|
60% |
|
| William Anderson Wittekind |
|
– – • |
2024-06-26 |
4 |
S |
$1.57 |
$78,500 |
I/I |
(50,000) |
1,193,499 |
|
61% |
|
| William Anderson Wittekind |
|
– – • |
2024-06-25 |
4 |
S |
$1.58 |
$31,600 |
I/I |
(20,000) |
1,243,499 |
|
67% |
|
| William Anderson Wittekind |
|
– – • |
2024-06-14 |
4 |
S |
$1.58 |
$79,000 |
I/I |
(50,000) |
1,263,499 |
|
69% |
|
| Brink Karen |
Director |
– • • |
2024-06-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,853,517) |
25,372,969 |
|
- |
|
| Sindlev Rene |
Director |
– • • |
2024-02-20 |
4 |
OE |
$0.53 |
$250,000 |
I/I |
471,699 |
13,605,297 |
|
- |
|
| Abildgaard Ole |
10% Owner |
– – • |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,436,190 |
7,898,482 |
|
- |
|
| Sindlev Rene |
Director |
– • • |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
701,260 |
13,133,598 |
|
- |
|
| Miller Avram |
Director |
– • – |
2023-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
|
- |
|
80 Records found
|
|
Page 1 of 4 |
|
|
0.03 (9.15%) 
